黑色素是通过TGF-β1 / Smad和EMT在膀纤维化中的新疗法

相关实验视频

Updated: Jul 1, 2025

Molecular Analysis of Endothelial-mesenchymal Transition Induced by Transforming Growth Factor-β Signaling

Molecular Analysis of Endothelial-mesenchymal Transition Induced by Transforming Growth Factor-β Signaling

Published on: August 3, 2018

Yang Zhang¹, Sun Gong¹, Weixin He¹

¹Department of Urology, Affiliated Hospital of Jiangsu University, Zhenjiang, Jiangsu, China.

|March 13, 2024

概括

黑色素 (MEL) 通过抑制TGF-β1/Smad通路和上皮-介质酶过渡 (EMT) 来有效降低膀纤维化. 这项研究确定了CCN1作为治疗膀纤维化的潜在治疗标.

科学领域:

泌尿器科泌尿器科泌尿器科泌尿器科
细胞生物学细胞生物学
分子生物学分子生物学

背景情况:

腺激素梅拉托尼 (MEL) 在各种器官中表现出已知的抗纤维素特性.
黑激素在膀纤维化中的确切作用机制在很大程度上仍未被探索.
这项研究研究了膀纤维化模型中的黑激素的作用和潜在机制.

研究的目的:

为了阐明黑激素对膀纤维化的治疗作用.
确定黑激素调节膀纤维化的分子机制.
探索膀纤维化治疗的潜在治疗点.

主要方法:

在体外研究中使用了用TGF-β1和黑素治疗的人类膀光滑肌细胞.
在小鼠体内诱导膀纤维化时,使用原胺硫酸和脂多糖,然后用美拉治疗.
在细胞和组织样本上进行了蛋白质组,生物信息和通路分析 (TGF-β1/Smad,EMT).

主要成果:

黑素治疗在体外逆转了TGF-β1诱导的纤维化标志物 (原III,α-SMA,E-cadherin,维丁,N-cadherin) 的变化.
在体内大鼠模型中观察到类似的抗纤维素作用.
定量蛋白质组学确定了CCN1和SQLE作为纤维化发展中的关键蛋白质,而黑激素减少了它们的表达.

结论:

黑色素有效地通过抑制TGF-β1/Smad通路和上皮-介质酶过渡 (EMT) 来减轻膀纤维化.
CCN1成为一个重要的蛋白质,涉及膀纤维化和潜在的治疗点.

更多相关视频

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

Development of an In Vitro Assay to Evaluate Contractile Function of Mesenchymal Cells that Underwent Epithelial-Mesenchymal Transition

Development of an In Vitro Assay to Evaluate Contractile Function of Mesenchymal Cells that Underwent Epithelial-Mesenchymal Transition

Published on: June 10, 2016

相关概念视频

TGF - β Signaling Pathway

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...